<?xml version="1.0" encoding="UTF-8"?>
<p>Antiviral drugs play an important role in the prevention and treatment of IBV. The neuraminidase inhibitors (NAI) include oseltamivir, intravenously injected peramivir, and inhalational zanamivir. However, recent clinical studies suggest that oseltamivir is less effective in treating IBV than IAV [
 <xref rid="B8" ref-type="bibr">8</xref>, 
 <xref rid="B9" ref-type="bibr">9</xref>]. Additionally, in clinical studies in Japan, when more than 100 children with influenza B or influenza A (H3N2) were administered oseltamivir, the results showed that oseltamivir was less effective for influenza B than influenza A in reducing the time the virus lasted or duration of fever [
 <xref rid="B10" ref-type="bibr">10</xref>â€“
 <xref rid="B12" ref-type="bibr">12</xref>].
</p>
